| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 58 |
| 1 | ADALIMUMAB | 19 |
| 2 | PREDNISONE | 14 |
| 3 | TADALAFIL | 14 |
| 4 | INFLIXIMAB | 13 |
| 5 | METHOTREXATE SODIUM | 11 |
| 6 | ASPIRIN | 10 |
| 7 | ASPIRIN 325 MG | 10 |
| 8 | ASPIRIN 81 MG | 10 |
| 9 | INTERFERON BETA-1A | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZINC OXIDE, OCTINOXATE, AND OCTISALATE | 1 | 0.1000 |
| 1 | PROPARACAINE HYDROCHLORIDE | 1 | 0.0019 |
| 2 | TRALOKINUMAB-LDRM | 8 | 0.0012 |
| 3 | DATOPOTAMAB DERUXTECAN | 1 | 0.0012 |
| 4 | BISMUTH SUBSALICYLATE | 6 | 0.0011 |
| 5 | NITISINONE | 1 | 0.0010 |
| 6 | NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION, 0.02%/0.005% | 1 | 0.0010 |
| 7 | BINIMETINIB | 7 | 0.0009 |
| 8 | CYCLOSERINE | 2 | 0.0009 |
| 9 | TERBINAFINE TABLETS 250 MG | 1 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 1 | Interleukin-13 Antagonist [EPC] | 8 | 0.0012 |
| 2 | Bismuth [EPC] | 6 | 0.0011 |
| 3 | Antiseptic [EPC] | 3 | 0.0007 |
| 4 | Neonatal Fc Receptor Blocker [EPC] | 3 | 0.0007 |
| 5 | Complement 5a Receptor Antagonist [EPC] | 3 | 0.0004 |
| 6 | Estrogen Agonist/Antagonist [EPC] | 1 | 0.0004 |
| 7 | Alkaloid [EPC] | 8 | 0.0003 |
| 8 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 9 | Antifibrinolytic Agent [EPC] | 2 | 0.0002 |